Full Text View
Tabular View
No Study Results Posted
Related Studies
Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
This study is currently recruiting participants.
Study NCT00270959   Information provided by National Institute of Mental Health (NIMH)
First Received: December 28, 2005   Last Updated: March 23, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

December 28, 2005
March 23, 2009
June 2006
  • PTSD ratings [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
  • Substance use [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
  • General functioning reports [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
  • PTSD ratings
  • Substance use
  • General functioning reports (measured 1 year post-injury)
Complete list of historical versions of study NCT00270959 on ClinicalTrials.gov Archive Site
  • Increased satisfaction with global care [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
  • Injury relapse [ Time Frame: Measured at Year 5 ] [ Designated as safety issue: Yes ]
  • Work, disability, and legal outcomes [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
  • Increased satisfaction with global care
  • Injury relapse
  • Work, disability, and legal outcomes (measured one year post-injury)
 
Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
Early Combined Intervention After Traumatic Injury

This study will evaluate the effectiveness of patient-centered collaborative care that combines behavioral therapy and drug therapy as compared to usual care in reducing symptoms of post-traumatic stress disorder in people who have survived a traumatic injury.

Approximately 2.5 million people in the U.S. are hospitalized each year having sustained injuries during a traumatic event. Injured trauma survivors are at high risk for developing post-traumatic stress disorder (PTSD) and other related conditions. In addition, many of these people experience several physical, financial, social, legal, and medical problems over the course of the year following the trauma. Effective interventions to prevent or remedy these issues have yet to be developed for individuals who undergo inpatient surgery following a traumatic injury and who then continue with outpatient treatment and community rehabilitation. This study will evaluate the effectiveness of patient-centered collaborative care that combines behavioral therapy and drug therapy as compared to usual care in reducing symptoms of PTSD and substance use. The study will also assess the intervention's effectiveness in increasing participants' general functioning and satisfaction with their care post-injury.

Participants in this open label study will be randomly assigned to receive either the standard care provided to injured trauma survivors or a combination of behavioral therapy and drug therapy. Participants assigned to receive the combination therapy may receive one or more of the following medications based on their individual needs: fluoxetine; sertraline; paroxetine; buspirone; propranolol; trazodone; and any of the benzodiazepines. Participants may begin receiving medication immediately or anytime within the 12 months post-injury. Behavioral therapy will also be administered on the basis of the participants' individual needs and may continue for up to 12 months. Participants will also take part in motivational interviews, the first of which will be conducted upon study entry in the hospital ward. Subsequent interviews will be conducted over the phone at Months 1, 3, 6, 9, and 12. Participants will be required to report to the study site only for the initial baseline visit. Outcome measures will include PTSD severity ratings, frequency of substance use, and general functioning reports.

Phase I
Interventional
Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study
Post-Traumatic Stress Disorder
  • Behavioral: Cognitive Behavioral Therapy
  • Behavioral: Motivational Interviewing
  • Drug: FDA-Approved Anti-Anxiety Medications
  • Behavioral: Standard Care Control
  • Experimental: Stepped collaborative care (combination of behavioral therapy and drug therapy)
  • Active Comparator: Standard care provided to injured trauma survivors

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
300
September 2009
September 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • English-speaking
  • Admitted to Harborview Medical Center with injuries sufficiently severe to require inpatient admission
  • Experienced a traumatic injury
  • Exhibits symptoms of PTSD while in the hospital ward

Exclusion Criteria:

  • History of head, spinal, or other injury that may prevent participation in the ward interview
  • Requires immediate intervention due to conditions such as self-inflicted injury, active psychosis, or active mania
  • Currently incarcerated
  • Likely to face criminal charges
  • Lives more than 50-100 miles from Harborview Medical Center
Both
18 Years and older
No
Contact: Grin Geiss Trusz, BA 206-744-9447 strusz@u.washington.edu
Contact: Douglas F. Zatzick, MD 206-744-6701 dzatzick@u.washington.edu
United States
 
 
NCT00270959
Douglas Zatzick, Associate Professor, University of Washington School of Medicine
DSIR 82-SECE
National Institute of Mental Health (NIMH)
 
Principal Investigator: Douglas F. Zatzick, MD University of Washington
National Institute of Mental Health (NIMH)
March 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.